Recursion
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Utah, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
41 S Rio Grande St, Salt Lake City, Utah...Phone Number
(385) 269-0203Website
www.recursion.comRevenue
$66.4 MillionStock Symbol
RXRXIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
1
5
1
2
About Recursion
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering. Our goal is to radically improve the lives of patients and industrialize drug discovery. Central to our mission is the Recursion Operating System, which combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets. We combine that with the Recursion Map, a suite of custom software, algorithms and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights.Explore more
Recursion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Recursion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Recursion
Check out if Recursion is spiking on competitors!
Recursion, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Recursion recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Recursion had a recent Job posting/layoffs
Product Launch: Get notified when Recursion launches new products
Check if Recursion has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Recursion has new funding data
Recommended Actions
Find VP level buyers at Recursion
Find 3 more new buyers
Compare Similar Companies to Recursion
Compare insights from companies similar to Recursion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$9.9M
51-200
Private
-
2000
TG
Thomas GrahamVice President, CISO, CMMC Provisional Assessor and Instructor
$6.4M
201-500
Private
-
2012
SE
Satya EnumulaGlobal BU Security Operations Center Threat Management Head
Company Profile Activity
Activity Insights
Recursion is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Recursion is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Recursion.
Recursion financials insights
Gather financial insights about Recursion, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Multiple Rounds
$4.9M
2016
Series A
$15M
2017
Debt
$4M
Series B
$60M
2018
Other Financing Round
$20.5M
2019
Series C
$121M
2020
Series D
$239M
2023
Other Financing Round
$50M
Recursion Tech Stack
A closer look at the technologies used by Recursion
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Recursion News & Media
Recursion to Participate in Upcoming Investor Conferences
Salt Lake City, UT, June 02, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation in an upcoming investor conference:Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
Salt Lake City, UT, May 29, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on May 26, 2026, the Compensation Committee of Recursion's Board of Directors approved the grant of inducement restricted stock unit (RSU) awards covering 2,991,840 shares of its class A common stock in the aggregate to 33 new employees under Recursion's 2024 Inducement Equity Incentive Plan (the “2024 Plan”). EachRecursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now?
The stock looks cheap, but appearances can be deceiving.Altitude Lab Portfolio Companies Surpass $205 Million in Funding, Marking a New Era for Early-Stage Biotechs in Salt Lake City
Altitude Lab portfolio companies surpass $205M in funding as startups advance clinical trials, sign global pharma deals, and reshape early-stage biotech.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Recursion
Sign Up For FreeTo access detailed company insights
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering. Our goal is to radically improve the lives of patients and industrialize drug discovery. Central to our mission is the Recursion Operating System, which combines an ad... Read More
